RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:News! Warrants 0.30 extended. Thanks Thor and Vestor . I guess i will put my trust in TLT management , like for the last +5 years . Let us hope for re commencement .
GLTA
vestor111 wrote: Hey Thor I have been looking for this update but can't seem to find it.
This was in the quarterly "update":
"...nor will any existing patient currently enrolled in the clinical study be treated a second time or be assessed by the Principal Investigator (“PI”) for their follow up visits, until the clinical study sites re-commence operations."
and this is from the financial NR:
- Clinical study sites status. Canadian clinical study sites are currently on hold for patient enrolment, treatment and follow-up due to the current COVID-19 pandemic. Theralase will continue to monitor the COVID-19 pandemic, provincial and federal guidelines in order to manage its business in compliance with all health and safety best practices. No new patients will be enrolled or treated at any Canadian clinical study site, nor will any existing patient currently enrolled in the clinical study be treated a second time or be assessed by a Principal Investigator ("PI") for their follow up visits, until the clinical study sites re-commence operation. Theralase is in constant communication with all Canadian clinical study sites for any update on re-commencing patient enrollment and treatment activities.
Could you provide a link to this update? (not on SH or company website.)